Therapeutic T cell engineering: CD19 CAR therapy and beyond

Ғылым және технология

Michel Sadelain, MD, PhD
Director, Center for Cell Engineering, Memorial Sloan Kettering Cancer Center
2017 Canada Gairdner Research Symposium
October 27, 2017

Пікірлер: 5

  • @sodomdamager
    @sodomdamager3 жыл бұрын

    A great presentation. Thanks for sharing

  • @dr.satyajeetsalunkheph.d.4367
    @dr.satyajeetsalunkheph.d.43673 жыл бұрын

    Great work

  • @SusieAspen
    @SusieAspen Жыл бұрын

    I had aphasia from oxaliplatin infusion; the nurses were not prepared for my reaction!!! I guess you have to weigh the side effects with the outcome, but it doesn't look like it's ready for colon cancer quite yet...but maybe in a couple of years there will be a new immunotherapy for colon cancer. What corporations produce these new therapies, by the way.

  • @user-rh2dt1kc5r
    @user-rh2dt1kc5r5 жыл бұрын

    а есть ссылка чтоб с переводом посмотреть?

Келесі